COVID-19 Vaccine Frequently Asked Questions
The City of Cambridge and the Cambridge Public Health Department recognize that there are many questions regarding the COVID-19 vaccine, including safety of the vaccines; trust in government and pharmaceutical companies who developed the vaccines; potential side effects; who should and should not receive the vaccine; and where vaccines will be administered. CPHD and the City will continue to update residents and those who work in Cambridge as more information becomes available.
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
COVID-19 Vaccine Frequently Asked Questions (as of December 23, 2020)
The City of Cambridge and the Cambridge Public Health Department recognize that there are many questions regarding the COVID-19 vaccine, including safety of the vaccines; trust in government and pharmaceutical companies who developed the vaccines; potential side effects; who should and should not receive the vaccine; and where vaccines will be administered. CPHD and the City will continue to update residents and those who work in Cambridge as more information becomes available.
Updates
The latest information relating to COVID-19 in the City of Cambridge